Ossiform® accepted into the ABHI 2026 U.S. Accelerator Program
Ossiform® accepted into the ABHI 2026 U.S. Accelerator Program
(February 6, 2026) Ossiform® announces its selection for the ABHI 2026 U.S. Accelerator, a respected program designed to support innovative health technology companies in entering and scaling within the U.S. healthcare market. Participation marks an important step in establishing the foundations for future U.S. activities and increasing visibility among key stakeholders.
The ABHI U.S. Accelerator provides structured market preparation support, tailored guidance, and curated introductions to healthcare decision-makers. The program also offers participating companies the opportunity to engage directly with leading hospitals, health systems, and industry partners. For Ossiform®, it represents a platform to present its technology to a broader audience of surgeons, hospital administrators, researchers, and payers as part of its long-term U.S. strategy.
Strengthening Ossiform’s position in the U.S. orthopedic landscape
Ossiform’s acceptance into the program reflects ongoing efforts to develop fully bio-integrative synthetic bone substitutes that bring precision, clinical relevance, and predictability to orthopedic reconstruction. The company’s 3D printed bone substitute technology is designed to address key challenges in the field by combining clinically informed design with advanced material science.
Planned U.S. visits in 2026
As part of the program, Ossiform will participate in several targeted U.S. market visits throughout the year:
- May: Nashville and Memphis
- October: Boston, New York, New Jersey, Philadelphia, Maryland, and Washington, D.C.
- December: Texas (Houston, Austin, and Dallas)
These visits will provide opportunities to build relationships with the people and organizations influencing the future of orthopedic care in the United States.
About Ossiform®
Ossiform® is a UK and Denmark based MedTech company that is forming a new generation of structural bioactive bone substitutes to reduce complications, improve functional outcomes, and accelerate recovery.
We are continuously working to redefine bone replacements through progressive research and close collaboration with physicians and industry partners. Our patient-centric approach and commitment to innovation, quality, and progress steer our efforts to provide best-in-class implant solutions that facilitate the natural forming of new bone.
Website: www.ossiform.com
LinkedIn: Ossiform
About the Association of British HealthTech Industries (ABHI)
ABHI is the UK’s leading industry association for health technology (HealthTech).
ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots, diagnostics and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is the largest employer in the broader Life Sciences sector, employing 196,000 people in 4,360 companies, with a combined turnover of £48bn. ABHI’s 400 members account for approximately 80% of the sector by value.
Website: www.abhi.org.uk
LinkedIn: ABHI